COLL Insider Trading Activity and SEC Form 4 Filings
Trump's trades in COLL
From his financial disclosures
-
0 purchases
$33K+
5 sales
Sale
Aug 31, 2026
Reported 38d later
$15K - $50K
Sale
Jul 29, 2026
Reported 55d later
$15K - $50K
Sale
Jul 8, 2026
Reported 76d later
$1K - $15K
Sale
May 15, 2026
Reported 47d later
$1K - $15K
Sale
Apr 30, 2026
Reported 62d later
$1K - $15K
Many orders in these accounts are placed by the account manager.
COLL insider trading summary
Over the past 12 months, insiders at Collegium Pharmaceutical, Inc (COLL) reported 13 sales worth $7.1M by 8 insiders and no open-market purchases on SEC Form 4. Net insider selling was $7.1M.
Latest COLL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| May 18, 2026 | John Gordon Freund | Insider | Sell | $681 (20 @ $34.05) |
| May 13, 2026 | Nancy Lurker | Insider | Sell | $162K (4,500 @ $35.97) |
| May 11, 2026 | Garen G Bohlin | Insider | Sell | $323K (8,700 @ $37.18) |
| Mar 18, 2026 | David Dieter | EVP & General Counsel | Sell | $488K (13,976 @ $34.92) |
| Mar 9, 2026 | David Dieter | EVP & General Counsel | Sell | $228K (6,224 @ $36.65) |
| Mar 3, 2026 | Scott Dreyer | EVP & Chief Commercial Officer | Sell | $1.9M (46,417 @ $40.36) |
| Mar 3, 2026 | Scott Dreyer | EVP & Chief Commercial Officer | Sell | $146K (3,559 @ $40.99) |
| Dec 8, 2025 | Scott Dreyer | EVP & Chief Commercial Officer | Sell | $315K (6,475 @ $48.66) |
| Dec 8, 2025 | Scott Dreyer | EVP & Chief Commercial Officer | Sell | $533K (11,125 @ $47.89) |
| Dec 5, 2025 | Rita J. Balice-Gordon | Insider | Sell | $172K (3,650 @ $47.03) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.